Loading...
Equasens S.A.
0R9T.L•LSE
Healthcare
Medical - Equipment & Services
£48.10
£0.10(0.21%)
Equasens S.A. (0R9T.L) Financial Performance & Income Statement Overview
Review Equasens S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.36%
↓ 1.36%
Operating Income Growth
-18.31%
↓ 18.31%
Net Income Growth
-23.06%
↓ 23.06%
Operating Cash Flow Growth
0.00%
Operating Margin
-19.34%
↓ 19.34%
Gross Margin
25.03%
↑ 25.03%
Net Profit Margin
16.10%
↑ 16.10%
ROE
15.72%
↑ 15.72%
ROIC
-14.14%
↓ 14.14%
Equasens S.A. (0R9T.L) Income Statement & Financial Overview
Review Equasens S.A.'s (0R9T.L) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $108.81M | $107.99M | $53.58M | $53.58M |
| Cost of Revenue | $108.81M | $79.26M | $36.06M | $36.06M |
| Gross Profit | $0.00 | $28.73M | $17.53M | $17.53M |
| Gross Profit Ratio | $0.00 | $0.27 | $0.33 | $0.33 |
| R&D Expenses | $0.00 | $0.00 | $1.55M | $1.55M |
| SG&A Expenses | $0.00 | $119000.00 | $213500.00 | $213500.00 |
| Operating Expenses | $170.97M | $8.50M | $3.11M | $3.11M |
| Total Costs & Expenses | -$170.97M | $87.76M | $39.17M | $39.17M |
| Interest Income | $0.00 | $5.34M | $0.00 | $1.11M |
| Interest Expense | $0.00 | $1.12M | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $7.24M | $974500.00 | $974500.00 |
| EBITDA | -$62.16M | $29.80M | $14.93M | $14.93M |
| EBITDA Ratio | -$0.57 | $0.28 | $0.28 | $0.28 |
| Operating Income | -$62.16M | $20.23M | $13.95M | $13.95M |
| Operating Income Ratio | -$0.57 | $0.19 | $0.26 | $0.26 |
| Other Income/Expenses (Net) | $62.16M | $1.48M | $1.16M | $1.16M |
| Income Before Tax | $0.00 | $21.71M | $15.24M | $15.24M |
| Income Before Tax Ratio | $0.00 | $0.20 | $0.28 | $0.28 |
| Income Tax Expense | $0.00 | $3.63M | $2.24M | $2.24M |
| Net Income | $17.72M | $17.19M | $12.53M | $12.53M |
| Net Income Ratio | $0.16 | $0.16 | $0.23 | $0.23 |
| EPS | $1.25 | $1.14 | $0.82 | $0.82 |
| Diluted EPS | $1.25 | $1.14 | $0.83 | $0.83 |
| Weighted Avg Shares Outstanding | $14.14M | $15.03M | $15.19M | $15.19M |
| Weighted Avg Shares Outstanding (Diluted) | $14.14M | $15.03M | $15.17M | $15.17M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan